RHO and Abnormal retinal morphology: Given that rod‐Bmal1KO retinas do not show obvious signs of retinal disease at 4 months, the identity of the genes that are up‐ or downregulated in this mutant with respect to the Bmalfl/+ control might also provide some hint of the molecular changes that underlie the synergy with P23H Rho effects.